Articles

Why Is Vivos Therapeutics (VVOS) Stock Down 35% Today?

Vivos Therapeutics stock is falling on Thursday but that's only after VVOS shares experienced a massive rally on Wednesday! More 

Comeback Candidates: 3 Industrial Stocks Set to Rebound

With concerns rising about the possibility of a global recession, the idea of targeting industrial stocks for investment seems risky. While the U.S. may offer the most insulation against financial headwinds, the global economy is incredibly interconnected. A slowdown in major markets could easily negatively impact our own standard of living. At the same time,… More 

Tech With Benefits: 7 Stocks Offering Growth and Passive Income

While innovation typically coincides exclusively with a growth-centric business model, that’s not always the case as these tech stocks to buy for growth and passive income demonstrates. With this category, investors can have their cake and eat it too. Primarily, the advantage that tech stocks for passive income offers is relevance. Sure, you can always… More 

The Next EV Leaders: 3 High-Growth Stocks to Drive Your Portfolio Forward

These three companies could be among the leading EV stocks over the long term, if their growth plans pan out according to expectations. More 

Looking for Value Stocks? 3 Warren Buffett Picks to Consider

These forgotten value stocks sport deep discounts despite signs of stability. Don't overlook their turnaround potential! More 

Follow the Leaders: 7 Stocks With Strong Insider Confidence

While no one methodology offers guarantees in the equities market, targeting stocks with insider buying could be a compelling and profitable approach. Basically, the thesis surrounds the nature of such transactions. Frankly, insiders sell securities for a variety of reasons, including mundane ones like tax considerations. However, there’s only one reason to buy a security:… More 

7 Top-Rated Blue-Chip Stocks That Analysts Are Loving Now

Consider these top-rated blue-chip stocks seeing more upside ahead, each of which has been upgraded recently by top analysts on Wall Street. More